Helius Medical Technologies Inc (HSDT):企業の製品パイプライン分析

◆英語タイトル:Helius Medical Technologies Inc (HSDT) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME2304164PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥243,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Helius Medical Technologies Inc (HMT) is a medical device company that provides neurological wellness solutions. The company provides development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides development of technologies as a potential treatment for neurological symptoms caused by disease or trauma. HMT provides PoNS device, an investigational device in development, enables physicians and patients to manage a host of neurological symptoms. The company offers devices which use results from the planned pivotal, multi-center mTBI study to support an application to FDA for commercial distribution. HMT is headquartered in Newtown, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Helius Medical Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Helius Medical Technologies Inc Company Overview
Helius Medical Technologies Inc Company Snapshot
Helius Medical Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Helius Medical Technologies Inc – Pipeline Analysis Overview
Helius Medical Technologies Inc – Key Facts
Helius Medical Technologies Inc – Major Products and Services
Helius Medical Technologies Inc Pipeline Products by Development Stage
Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
Helius Medical Technologies Inc Pipeline Products Overview
PoNS Device – Cerebral Palsy
PoNS Device – Cerebral Palsy Product Overview
PoNS Device – Chronic Balance Disorder
PoNS Device – Chronic Balance Disorder Product Overview
PoNS Device – Chronic Balance Disorder Clinical Trial
PoNS Device – Depression
PoNS Device – Depression Product Overview
PoNS Device – Facial Nerve Palsy
PoNS Device – Facial Nerve Palsy Product Overview
PoNS Device – Multiple Sclerosis
PoNS Device – Multiple Sclerosis Product Overview
PoNS Device – Parkinson’s Disease
PoNS Device – Parkinson’s Disease Product Overview
PoNS Device – PTSD
PoNS Device – PTSD Product Overview
PoNS Device – Stroke
PoNS Device – Stroke Product Overview
Helius Medical Technologies Inc – Key Competitors
Helius Medical Technologies Inc – Key Employees
Helius Medical Technologies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Helius Medical Technologies Inc, Recent Developments
Jul 14, 2020: Helius Medical announces the dismissal of the shareholder class action lawsuit
Mar 09, 2020: Helius Medical Technologies provides details on five recently authorized PoNS Treatment clinics
Mar 02, 2020: Helius Medical Technologies reports preliminary unaudited fourth quarter and full year unaudited 2019 financial results
Feb 24, 2020: Helius Medical CEO Philippe Deschamps to Deliver Congressional Briefing on the Latest Technologies, Innovations and Policies in Clinical Neuroscience
Feb 07, 2020: Helius Medical Technologies welcomes Cline Medical Centre as an authorized PoNS Treatment Clinic in Nanaimo, BC
Jan 16, 2020: Helius Medical Technologies and University Health Network (UHN) have signed an agreement for UHN and three neuro-rehabilitation centers to perform a clinical experience program of the PoNS Device in Canada
Jan 10, 2020: Helius Medical Technologies awarded pioneer technology development award
Dec 19, 2019: Independent research published show positive results on translingual neurostimulation plus physical therapy with statistically significant improvement in balance and gait scores and the outcomes were sustained for 12 weeks after discontinuing treatme
Nov 19, 2019: Helius Medical Technologies announces addition of P3 Health as new authorized PoNS Treatment Clinic in Toronto, Canada
Nov 12, 2019: Helius Medical Technologies reports third quarter 2019 financial results and provides business
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Helius Medical Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Helius Medical Technologies Inc Pipeline Products by Equipment Type
Helius Medical Technologies Inc Pipeline Products by Indication
Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
Helius Medical Technologies Inc, Key Facts
Helius Medical Technologies Inc, Major Products and Services
Helius Medical Technologies Inc Number of Pipeline Products by Development Stage
Helius Medical Technologies Inc Pipeline Products Summary by Development Stage
Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
Helius Medical Technologies Inc Ongoing Clinical Trials Summary
PoNS Device - Cerebral Palsy - Product Status
PoNS Device - Cerebral Palsy - Product Description
PoNS Device - Chronic Balance Disorder - Product Status
PoNS Device - Chronic Balance Disorder - Product Description
PoNS Device - Chronic Balance Disorder - A Comprehensive Study of Investigational PoNS Therapy in Healthy Adults
PoNS Device - Chronic Balance Disorder - An Open-label Study of Safety and Effectiveness of the Portable Neuromodulation Stimulator (PoNS) Treatment for Subjects with a Chronic Balance Deficit Due to Mild-to-moderate Traumatic Brain Injury (TBI)
PoNS Device - Chronic Balance Disorder - An Open-label Study of Safety and Effectiveness of the Portable Neuromodulation Stimulator (PoNS) Treatment for Subjects with a Chronic Balance Deficit Due to Mild-to-moderate Traumatic Brain Injury (TBI)
PoNS Device - Chronic Balance Disorder - An Open-label Study of Safety and Effectiveness of the Portable Neuromodulation Stimulator (PoNS) Treatment for Subjects with a Chronic Balance Deficit Due to Mild-to-moderate Traumatic Brain Injury (TBI)
PoNS Device - Chronic Balance Disorder - An Open-label Study of Safety and Effectiveness of the Portable Neuromodulation Stimulator (PoNS) Treatment for Subjects with a Chronic Balance Deficit Due to Mild-to-moderate Traumatic Brain Injury (TBI)
PoNS Device - Depression - Product Status
PoNS Device - Depression - Product Description
PoNS Device - Facial Nerve Palsy - Product Status
PoNS Device - Facial Nerve Palsy - Product Description
PoNS Device - Multiple Sclerosis - Product Status
PoNS Device - Multiple Sclerosis - Product Description
PoNS Device - Parkinson’s Disease - Product Status
PoNS Device - Parkinson’s Disease - Product Description
PoNS Device - PTSD - Product Status
PoNS Device - PTSD - Product Description
PoNS Device - Stroke - Product Status
PoNS Device - Stroke - Product Description
Helius Medical Technologies Inc, Key Employees
Helius Medical Technologies Inc, Subsidiaries
Glossary

★海外企業調査レポート[Helius Medical Technologies Inc (HSDT):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CIncinnati Children’s Hospital Medical Center:企業のM&A・事業提携・投資動向
    CIncinnati Children's Hospital Medical Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIncinnati Children's Hospital Medical Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • MegaChips Corp (6875):企業の財務・戦略的SWOT分析
    MegaChips Corp (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oil and Natural Gas Corporation Limited:戦略・SWOT・企業財務分析
    Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Xeikon N.V.:企業の戦略的SWOT分析
    Xeikon N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Coventry Group Ltd (CYG):企業の財務・戦略的SWOT分析
    Coventry Group Ltd (CYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • WNDM Medical Inc (WNDM):製薬・医療:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Oswaldo Cruz Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Oswaldo Cruz Foundation (Oswaldo Cruz) is a provider of research development, vaccines production, drugs, reagents and diagnostic kits. The foundation provides research in experimental models of disease, infectious agent vector biology, information and communication in health, management of …
  • Micell Technologies Inc:企業の製品パイプライン分析2018
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • Hellenic Petroleum SA (ELPE):企業の財務・戦略的SWOT分析
    Hellenic Petroleum SA (ELPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • William Hill plc (WMH):企業の財務・戦略的SWOT分析
    William Hill plc (WMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cantel Medical Corp (CMD):企業の財務・戦略的SWOT分析
    Cantel Medical Corp (CMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sui Northern Gas Pipelines Ltd (SNGP):企業の財務・戦略的SWOT分析
    Sui Northern Gas Pipelines Ltd (SNGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Taita Chemical Co, Ltd (1309):企業の財務・戦略的SWOT分析
    Taita Chemical Co, Ltd (1309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Senhwa Biosciences Inc (6492)-製薬・医療分野:企業M&A・提携分析
    Summary Senhwa Biosciences Inc (Senhwa) is a drug development company that develops small molecule drugs for the treatment of cancer. The company’s products include CX-5461 and CX-4945. Its CX-5461 is a p53 activating Pol I inhibitor and anticancer compound for treating hematological malignancies. S …
  • Ablynx NV (ABLX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ablynx NV (Ablynx) is a biopharmaceutical company that focuses on developing Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional properties of nat …
  • Varian Medical Systems Inc (VAR)-医療機器分野:企業M&A・提携分析
    Summary Varian Medical Systems Inc (Varian) designs, manufactures and sells equipment and software for the diagnosis and treatment of cancer and other medical conditions through radiotherapy, radiosurgery, proton therapy and brachytherapy. Its major products include brachytherapy afterloaders, linea …
  • KCC Corp (002380):企業の財務・戦略的SWOT分析
    KCC Corp (002380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Selecta Biosciences Inc:企業のM&A・事業提携・投資動向
    Selecta Biosciences Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Selecta Biosciences Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Hoverink Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Hoverink Biotechnologies Inc (Hoverink) formerly Hoverink International Holdings Inc, is a preclinical biopharmaceutical company that discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and on …
  • Hitachi Zosen Corporation:戦略・SWOT・企業財務分析
    Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report Summary Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆